Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,381
Financial Services 1,863
Healthcare 1,091
Technology 1,046
Industrials 670
Consumer Cyclical 492
Basic Materials 338
Consumer Defensive 246
Communication Services 208
Utilities 182
Energy 163
Real Estate 82
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
A
Deeply overvalued
AGILENT TECHNOLOGIES, INC.
Price$168.17
Model IV$75.29
P/IV2.22
Premium +123%
Return to IV: -55.2%
Owner yield 2.5%
10-yr IRR 0.7% · moderate
Market implies +17.2%/yr
vs model +7.7% · above model
AA
Deeply overvalued
Alcoa Corp
Price$42.83
Model IV$11.61
P/IV3.82
Premium +269%
Return to IV: -72.9%
Owner yield 0.2%
10-yr IRR -27.6% · steady
Market implies +21.6%/yr
vs model +2.5% · above model
AAAU
Valuation N/A
Goldman Sachs Physical Gold ETF
Price$42.15
Model IV—
P/IV—
AACB
Valuation N/A
AACB
Price$10.59
Model IV—
P/IV—
AACBR
Valuation N/A
AACBR
Price$0.01
Model IV—
P/IV—
AACBU
Valuation N/A
AACBU
Price$10.70
Model IV—
P/IV—
AACG
Deeply overvalued
ATA Creativity Global
Price$0.74
Model IV$0.25
P/IV3.25
Premium +201%
Return to IV: -66.8%
Market implies +13.3%/yr
vs model +4.8% · above model
AACI
Valuation N/A
Armada Acquisition Corp. III
Price$10.06
Model IV—
P/IV—
AACIU
Valuation N/A
Armada Acquisition Corp. III
Price$10.32
Model IV—
P/IV—
AACIW
Valuation N/A
Armada Acquisition Corp. III
Price$0.23
Model IV—
P/IV—
AACO
Valuation N/A
Abony Acquisition Corp. I
Price$9.98
Model IV—
P/IV—
AACOU
Valuation N/A
Abony Acquisition Corp. I
Price$10.10
Model IV—
P/IV—
AACOW
Valuation N/A
Abony Acquisition Corp. I
Price$0.37
Model IV—
P/IV—
AACP
Valuation N/A
Apogee Acquisition Corp
Price$10.07
Model IV—
P/IV—
AACPU
Valuation N/A
Apogee Acquisition Corp
Price$10.28
Model IV—
P/IV—
AAL
Undervalued
American Airlines Group Inc.
Price$12.80
Model IV$17.78
P/IV0.77
Discount 28%
Return to IV: +38.9%
Owner yield 6.2%
10-yr IRR 10.3% · steady
Market implies -1.0%/yr
vs model +5.0% · below model
AAME
Deeply undervalued
ATLANTIC AMERICAN CORP
Price$1.21
Model IV$1.91
P/IV0.71
Discount 37%
Return to IV: +58.1%
AAMI
Valuation N/A
Acadian Asset Management Inc.
Price$93.30
Model IV—
P/IV—
Market implies +108.2%/yr
AAOI
Valuation N/A
APPLIED OPTOELECTRONICS, INC.
Price$105.90
Model IV—
P/IV—
Market implies +110.9%/yr
AAON
Valuation N/A
AAON, INC.
Price$85.95
Model IV—
P/IV—
Market implies +63.5%/yr
AAP
Valuation N/A
ADVANCE AUTO PARTS INC
Price$42.40
Model IV—
P/IV—
Market implies +26.4%/yr
AAPG
Valuation N/A
ASCENTAGE PHARMA GROUP INTERNATIONAL
Price$14.55
Model IV—
P/IV—
Market implies +19.4%/yr
AAPL
Deeply overvalued
Apple Inc.
Price$340.42
Model IV$133.82
P/IV2.49
Premium +154%
Return to IV: -60.7%
Owner yield 1.8%
10-yr IRR -2.2% · moderate
Market implies +20.5%/yr
vs model +9.4% · above model
AARD
Valuation N/A
Aardvark Therapeutics, Inc.
Price$4.71
Model IV—
P/IV—
AAT
Overvalued
American Assets Trust, Inc.
Price$21.61
Model IV$17.24
P/IV1.25
Premium +25%
Return to IV: -20.2%
AAUC
Deeply overvalued
Allied Gold Corp
Price$19.63
Model IV$5.46
P/IV4.20
Premium +260%
Return to IV: -72.2%
Market implies +24.4%/yr
vs model +8.0% · above model
AB
Deeply undervalued
ALLIANCEBERNSTEIN HOLDING L.P.
Price$35.30
Model IV$64.10
P/IV0.56
Discount 45%
Return to IV: +81.6%
Market implies -4.7%/yr
vs model +3.8% · below model
ABAT
Valuation N/A
AMERICAN BATTERY TECHNOLOGY Co
Price$2.05
Model IV—
P/IV—
Market implies +54.3%/yr
vs model +5.0% · above model
ABBV
Fairly valued
AbbVie Inc.
Price$272.42
Model IV$249.16
P/IV1.06
Premium +9%
Return to IV: -8.5%
Owner yield 3.8%
10-yr IRR 5.7% · moderate
Market implies +7.3%/yr
vs model +7.6% · in line
ABCB
Overvalued
Ameris Bancorp
Price$79.66
Model IV$63.82
P/IV1.29
Premium +25%
Return to IV: -19.9%
ABCL
Valuation N/A
AbCellera Biologics Inc.
Price$12.02
Model IV—
P/IV—
Market implies +91.1%/yr
ABEO
Valuation N/A
ABEONA THERAPEUTICS INC.
Price$4.96
Model IV—
P/IV—
Market implies +47.7%/yr
ABEV
Undervalued
AMBEV S.A.
Price$3.19
Model IV$4.43
P/IV0.68
Discount 28%
Return to IV: +38.9%
Owner yield 7.4%
10-yr IRR 12.3% · steady
Market implies -0.4%/yr
vs model +4.3% · below model
ABG
Deeply undervalued
ASBURY AUTOMOTIVE GROUP INC
Price$168.96
Model IV$503.14
P/IV0.37
Discount 66%
Return to IV: +197.8%
Market implies -9.5%/yr
vs model +7.0% · below model
ABLV
Deeply overvalued
Able View Global Inc.
Price$2.25
Model IV$0.24
P/IV5.46
Premium +844%
Return to IV: -89.4%
Market implies +34.5%/yr
vs model +4.8% · above model
ABLVW
Valuation N/A
Able View Global Inc.
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr
ABM
Overvalued
ABM INDUSTRIES INC /DE/
Price$49.89
Model IV$42.16
P/IV1.18
Premium +18%
Return to IV: -15.5%
Owner yield 4.4%
10-yr IRR 10.2% · moderate
Market implies +11.1%/yr
vs model +11.1% · in line
ABNB
Deeply overvalued
Airbnb, Inc.
Price$163.23
Model IV$77.25
P/IV2.04
Premium +111%
Return to IV: -52.7%
Owner yield 2.1%
10-yr IRR 1.6% · moderate
Market implies +19.8%/yr
vs model +12.0% · above model
ABOS
Valuation N/A
Acumen Pharmaceuticals, Inc.
Price$2.10
Model IV—
P/IV—
ABR
Valuation N/A
ARBOR REALTY TRUST INC
Price$3.09
Model IV—
P/IV—
ABSI
Valuation N/A
Absci Corp
Price$8.94
Model IV—
P/IV—
Market implies +93.1%/yr
ABT
Fairly valued
ABBOTT LABORATORIES
Price$98.49
Model IV$90.43
P/IV1.12
Premium +9%
Return to IV: -8.2%
Owner yield 3.3%
10-yr IRR 3.4% · moderate
Market implies +7.0%/yr
vs model +7.2% · in line
ABTC
Valuation N/A
American Bitcoin Corp.
Price$7.75
Model IV—
P/IV—
Market implies +42.4%/yr
ABTS
Deeply undervalued
Abits Group Inc
Price$1.23
Model IV$6.20
P/IV0.20
Discount 80%
Return to IV: +402.8%
Market implies -29.7%/yr
vs model +50.0% · below model
ABUS
Valuation N/A
Arbutus Biopharma Corp
Price$4.18
Model IV—
P/IV—
Market implies +54.9%/yr
ABVC
Valuation N/A
ABVC BIOPHARMA, INC.
Price$0.98
Model IV—
P/IV—
Market implies +65.2%/yr
ABVE
Valuation N/A
ABVE
Price$0.11
Model IV—
P/IV—
ABVEW
Valuation N/A
ABVEW
Price$0.02
Model IV—
P/IV—
ABVX
Valuation N/A
Abivax S.A.
Price$89.05
Model IV—
P/IV—
ABX
Deeply overvalued
Abacus Global Management, Inc.
Price$8.32
Model IV$2.45
P/IV3.39
Premium +240%
Return to IV: -70.6%
Market implies +14.2%/yr
vs model +15.0% · in line
ABXL
Valuation N/A
Abacus Global Management, Inc.
Price$25.28
Model IV—
P/IV—
Market implies +20.8%/yr
ACA
Deeply overvalued
Arcosa, Inc.
Price$146.50
Model IV$51.43
P/IV2.85
Premium +185%
Return to IV: -64.9%
Owner yield 2.2%
10-yr IRR -1.5% · moderate
Market implies +20.0%/yr
vs model +6.9% · above model
ACAA
Valuation N/A
Averin Capital Acquisition Corp.
Price$10.02
Model IV—
P/IV—
ACAAU
Valuation N/A
Averin Capital Acquisition Corp.
Price$10.15
Model IV—
P/IV—
ACAAW
Valuation N/A
Averin Capital Acquisition Corp.
Price$0.70
Model IV—
P/IV—
ACAD
Deeply overvalued
ACADIA PHARMACEUTICALS INC
Price$19.58
Model IV$8.75
P/IV3.02
Premium +124%
Return to IV: -55.3%
Market implies +21.4%/yr
vs model +13.6% · above model
ACB
Fairly valued
AURORA CANNABIS INC
Price$4.43
Model IV$4.74
P/IV0.90
Discount 7%
Return to IV: +7.1%
Market implies -3.5%/yr
vs model +5.4% · below model
ACCL
Deeply overvalued
Acco Group Holdings Ltd
Price$2.50
Model IV$0.88
P/IV2.85
Premium +185%
Return to IV: -64.9%
Owner yield 1.8%
10-yr IRR -2.3% · moderate
Market implies +17.8%/yr
vs model +8.7% · above model
ACCO
Undervalued
ACCO BRANDS Corp
Price$4.46
Model IV$5.75
P/IV0.75
Discount 22%
Return to IV: +28.9%
Owner yield 21.8%
10-yr IRR 32.1% · steady
Market implies -1.6%/yr
vs model +3.5% · below model
ACCS
Deeply overvalued
ACCESS Newswire Inc.
Price$4.60
Model IV$2.48
P/IV1.93
Premium +85%
Return to IV: -46.0%
Market implies +7.3%/yr
vs model +2.0% · above model